Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Angiotensin-Converting-Enzyme Inhibitors (Ace Inhibitors) and Angiotensin Ii Receptor Blocker (Arb) Use in Covid-19 Prevention or Treatment: A Paradox Publisher Pubmed



Javanmard SH1 ; Heshmatghahdarijani K2 ; Vaseghi G3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Infection Control and Hospital Epidemiology Published:2021


Abstract

[No abstract available]
Experts (# of related papers)
Other Related Docs
9. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
16. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
23. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)
28. Cytokines and Micrornas in Sars-Cov-2: What Do We Know?, Molecular Therapy Nucleic Acids (2022)
40. The Molecular Basis of Covid-19 Pathogenesis, Conventional and Nanomedicine Therapy, International Journal of Molecular Sciences (2021)
42. View of the Renin-Angiotensin System in Acute Kidney Injury Induced by Renal Ischemia-Reperfusion Injury, JRAAS - Journal of the Renin-Angiotensin-Aldosterone System (2022)